| Date Filed | Type | Description |
| 06/30/2021 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $22.3477, valued at
$223.5k
Exercised 2,031 options to buy
@ $0.3, valued at
$609.3
Exercised 7,969 options to buy
@ $0.39, valued at
$3.1k
|
|
| 06/21/2021 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 4,389 shares
@ $0
Granted 19,620 options to buy
@ $21.97, valued at
$431.1k
|
|
| 12/29/2020 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 924 shares
@ $20.0999, valued at
$18.6k
|
|
| 12/23/2020 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 18,974 shares
@ $20.3279, valued at
$385.7k
Sold 13,118 shares
@ $20.1827, valued at
$264.8k
|
|
| 12/10/2020 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 13,161 shares
@ $20.188, valued at
$265.7k
Sold 5,773 shares
@ $20.3159, valued at
$117.3k
Sold 546 shares
@ $20.0018, valued at
$10.9k
|
|
| 12/03/2020 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 520 shares
@ $20.0947, valued at
$10.4k
|
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $17.59, valued at
$351.8k
|
|
| 09/03/2019 |
4
| RUDNICK SETH (Director) has filed a Form 4 on Liquidia Technologies Inc|
Txns:
| Granted 7,500 options to buy
@ $4.52, valued at
$33.9k
|
|
| 06/14/2019 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $18.47, valued at
$369.4k
|
|
| 12/04/2018 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 9,884 shares
@ $39.3066, valued at
$388.5k
Sold 116 shares
@ $40, valued at
$4.6k
Exercised 607 options to buy
@ $0.39, valued at
$236.7
Exercised 9,393 options to buy
@ $0.39, valued at
$3.7k
|
|
| 11/07/2018 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $41.5347, valued at
$415.3k
Exercised 10,000 options to buy
@ $0.39, valued at
$3.9k
|
|
| 10/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2018 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 9,500 shares
@ $59.9293, valued at
$569.3k
Sold 500 shares
@ $60.31, valued at
$30.2k
Exercised 10,000 options to buy
@ $0.39, valued at
$3.9k
|
|
| 08/06/2018 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 10,000 shares
@ $50.6901, valued at
$506.9k
Exercised 10,000 options to buy
@ $0.39, valued at
$3.9k
|
|
| 07/25/2018 |
3
| RUDNICK SETH (Director) has filed a Form 3 on Liquidia Technologies Inc |
| 06/11/2018 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $38.39, valued at
$383.9k
|
|
| 07/13/2017 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $15.55, valued at
$311k
|
|
| 05/24/2017 |
4
| RUDNICK SETH (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Converted 2,757 shares
@ $0
Converted 8,271 preferred shares
@ $0 |
|
| 05/19/2017 |
3/A
| RUDNICK SETH (Director) has filed a Form 3/A on G1 Therapeutics, Inc. |
| 05/16/2017 |
3
| RUDNICK SETH (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 05/12/2017 |
4
| RUDNICK SETH (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 03/17/2017 |
4
| RUDNICK SETH (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 12/12/2016 |
4
| RUDNICK SETH (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 11/15/2016 |
4
| RUDNICK SETH (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc. |
| 06/20/2016 |
4
| RUDNICK SETH (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Granted 7,500 shares
@ $0
Granted 15,000 options to buy
@ $3.42, valued at
$51.3k
|
|
| 02/09/2016 |
4
| RUDNICK SETH (Director) has filed a Form 4 on Aralez Pharmaceuticals Inc.|
Txns:
| Acquired 47,501 shares
@ $0 |
|
| 10/08/2015 |
4
| RUDNICK SETH (Director) has filed a Form 4 on SQUARE 1 FINANCIAL INC|
Txns:
| Disposed/sold 31,145 shares
@ $0
Disposed/sold 1,031 restricted stock units
@ $0 |
|
| 06/25/2015 |
4
| RUDNICK SETH (Director) has filed a Form 4 on POZEN INC /NC|
Txns:
| Paid exercise price by delivering 13,987 shares
@ $12.02, valued at
$168.1k
Exercised 3,053 options to buy
@ $3.93, valued at
$12k
Exercised 24,430 options to buy
@ $3.93, valued at
$96k
Exercised 6,107 options to buy
@ $5.4, valued at
$33k
Exercised 6,107 options to buy
@ $4.44, valued at
$27.1k
|
|
| 06/12/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/05/2015 |
4
| RUDNICK SETH (Director) has filed a Form 4 on SQUARE 1 FINANCIAL INC|
Txns:
| Granted 1,031 shares
@ $0 |
|
| 06/18/2014 |
4
| RUDNICK SETH (Director) has filed a Form 4 on Square 1 Financial Inc|
Txns:
| Converted 30,000 shares
@ $0
Converted 300 options to buy
@ $0 |
|
| 06/09/2014 |
4
| RUDNICK SETH (Director) has filed a Form 4 on POZEN INC /NC|
Txns:
| Granted 9,291 shares
@ $0 |
|
| 06/11/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|